^
FIP1L1-PDGFRA fusion
Chronic Eosinophilic Leukemia
imatinib
Sensitive: A1 - Approval
KIT M541L
Chronic Eosinophilic Leukemia
imatinib
Sensitive: C3 – Early Trials
PCM1-JAK2 fusion
Chronic Eosinophilic Leukemia
ruxolitinib
Sensitive: C3 – Early Trials
FIP1L1-PDGFRA fusion
Chronic Eosinophilic Leukemia
YD312
Sensitive: C4 – Case Studies